Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Patamia

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|January 11, 2022
Green Efficient One-Pot Synthesis and Separation of Nitrones in Water Assisted by a Self-Assembled NanoreactorVincenzo Patamia, Giuseppe Floresta, Venerando Pistarà, et al.
Expert Opinion on Drug Discovery|July 17, 2023
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?Giuseppe Floresta, Chiara Zagni, Vincenzo Patamia, et al.
European Journal of Medicinal Chemistry|July 19, 2022
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022Giuseppe Floresta, Vincenzo Patamia, Chiara Zagni, et al.
Scientific Reports|October 9, 2024
Cyclic carbamates based on (R)-(+)-limonene oxide for ring-opening polymerizationLucia Rubino, Vincenzo Patamia, Antonio Rescifina, et al.
Marine Drugs|November 6, 2019
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling ApproachGiuseppe Floresta, Davide Gentile, Giancarlo Perrini, et al.
Chemsuschem|October 23, 2024
Learning Strategies from Nature's Blueprint to Cyclic Carbonate SynthesisErika Saccullo, Vincenzo Patamia, Chiara Zagni, et al.
International Journal of Molecular Sciences|March 25, 2022
Artificial Intelligence Technologies for COVID-19 De Novo Drug DesignGiuseppe Floresta, Chiara Zagni, Davide Gentile, et al.
Current Medicinal Chemistry|June 15, 2021
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological AspectsDavide Gentile, Vincenzo Patamia, Virginia Fuochi, et al.
International Journal of Molecular Sciences|January 21, 2023
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking StudyVincenzo Patamia, Giuseppe Floresta, Chiara Zagni, et al.
International Journal of Molecular Sciences|September 9, 2022
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion ProcessDavide Gentile, Alessandro Coco, Vincenzo Patamia, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|January 11, 2022
Green Efficient One-Pot Synthesis and Separation of Nitrones in Water Assisted by a Self-Assembled NanoreactorVincenzo Patamia, Giuseppe Floresta, Venerando Pistarà, et al.
Expert Opinion on Drug Discovery|July 17, 2023
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?Giuseppe Floresta, Chiara Zagni, Vincenzo Patamia, et al.
European Journal of Medicinal Chemistry|July 19, 2022
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022Giuseppe Floresta, Vincenzo Patamia, Chiara Zagni, et al.
Scientific Reports|October 9, 2024
Cyclic carbamates based on (R)-(+)-limonene oxide for ring-opening polymerizationLucia Rubino, Vincenzo Patamia, Antonio Rescifina, et al.
Marine Drugs|November 6, 2019
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling ApproachGiuseppe Floresta, Davide Gentile, Giancarlo Perrini, et al.
Chemsuschem|October 23, 2024
Learning Strategies from Nature's Blueprint to Cyclic Carbonate SynthesisErika Saccullo, Vincenzo Patamia, Chiara Zagni, et al.
International Journal of Molecular Sciences|March 25, 2022
Artificial Intelligence Technologies for COVID-19 De Novo Drug DesignGiuseppe Floresta, Chiara Zagni, Davide Gentile, et al.
Current Medicinal Chemistry|June 15, 2021
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological AspectsDavide Gentile, Vincenzo Patamia, Virginia Fuochi, et al.
International Journal of Molecular Sciences|January 21, 2023
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking StudyVincenzo Patamia, Giuseppe Floresta, Chiara Zagni, et al.
International Journal of Molecular Sciences|September 9, 2022
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion ProcessDavide Gentile, Alessandro Coco, Vincenzo Patamia, et al.
Pageof 5